| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid binding | 1.93e-08 | 28 | 60 | 5 | GO:0001972 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 6.26e-08 | 35 | 60 | 5 | GO:0015020 | |
| GeneOntologyMolecularFunction | retinoid binding | 3.20e-07 | 48 | 60 | 5 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 3.56e-07 | 49 | 60 | 5 | GO:0019840 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 1.74e-05 | 107 | 60 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 4.04e-05 | 211 | 60 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 4.62e-05 | 66 | 60 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | fatty acid binding | 5.50e-05 | 69 | 60 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | dermatan 4-sulfotransferase | 8.83e-05 | 5 | 60 | 2 | GO:0001537 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 9.62e-05 | 153 | 60 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 2.23e-04 | 288 | 60 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | histone H3K14 acetyltransferase activity | 3.15e-04 | 9 | 60 | 2 | GO:0036408 | |
| GeneOntologyMolecularFunction | steroid binding | 6.87e-04 | 133 | 60 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 7.53e-04 | 239 | 60 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 9.09e-04 | 15 | 60 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | organic acid binding | 9.89e-04 | 254 | 60 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.32e-03 | 18 | 60 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | enzyme inhibitor activity | 1.91e-03 | 435 | 60 | 6 | GO:0004857 | |
| GeneOntologyMolecularFunction | clathrin adaptor activity | 1.97e-03 | 22 | 60 | 2 | GO:0035615 | |
| GeneOntologyMolecularFunction | cargo adaptor activity | 2.55e-03 | 25 | 60 | 2 | GO:0140312 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 2.91e-03 | 815 | 60 | 8 | GO:0042803 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.19e-03 | 28 | 60 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | protein kinase binding | 4.41e-03 | 873 | 60 | 8 | GO:0019901 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.53e-03 | 37 | 60 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 6.83e-03 | 398 | 60 | 5 | GO:0046982 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 9.64e-13 | 6 | 59 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.04e-10 | 13 | 59 | 5 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 3.01e-10 | 5 | 59 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 9.02e-10 | 6 | 59 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 9.02e-10 | 6 | 59 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 3.16e-09 | 21 | 59 | 5 | GO:0052695 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.01e-08 | 26 | 59 | 5 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.01e-08 | 26 | 59 | 5 | GO:0006063 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.25e-08 | 10 | 59 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.25e-08 | 10 | 59 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.21e-07 | 5 | 59 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.48e-07 | 21 | 59 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.63e-06 | 34 | 59 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 4.80e-06 | 12 | 59 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 7.28e-06 | 94 | 59 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.48e-05 | 52 | 59 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 4.05e-05 | 67 | 59 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 5.17e-05 | 141 | 59 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 2.04e-04 | 40 | 59 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | 3.34e-04 | 210 | 59 | 5 | GO:0060294 | |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | 3.72e-04 | 215 | 59 | 5 | GO:0001539 | |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | 3.72e-04 | 215 | 59 | 5 | GO:0060285 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 4.31e-04 | 222 | 59 | 5 | GO:0071466 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 7.70e-04 | 144 | 59 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | cilium movement | 8.95e-04 | 261 | 59 | 5 | GO:0003341 | |
| GeneOntologyCellularComponent | MOZ/MORF histone acetyltransferase complex | 1.69e-04 | 7 | 60 | 2 | GO:0070776 | |
| GeneOntologyCellularComponent | H3 histone acetyltransferase complex | 2.24e-04 | 8 | 60 | 2 | GO:0070775 | |
| GeneOntologyCellularComponent | AP-1 adaptor complex | 5.25e-04 | 12 | 60 | 2 | GO:0030121 | |
| HumanPheno | Irregularly shaped sperm tail | 2.66e-05 | 15 | 21 | 3 | HP:0033393 | |
| Domain | UDPGT | 5.18e-09 | 21 | 59 | 5 | PS00375 | |
| Domain | UDPGT | 5.18e-09 | 21 | 59 | 5 | PF00201 | |
| Domain | UDP_glucos_trans | 5.18e-09 | 21 | 59 | 5 | IPR002213 | |
| Domain | Znf_C2H2-like | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 MATR3 ZNF780B ZBTB4 ZNF749 ZNF625 | 3.38e-05 | 796 | 59 | 11 | IPR015880 |
| Domain | ZnF_C2H2 | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 MATR3 ZNF780B ZBTB4 ZNF749 ZNF625 | 3.88e-05 | 808 | 59 | 11 | SM00355 |
| Domain | - | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 4.74e-05 | 679 | 59 | 10 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 5.69e-05 | 694 | 59 | 10 | IPR013087 |
| Domain | MOZ_SAS | 9.75e-05 | 5 | 59 | 2 | PF01853 | |
| Domain | HAT_MYST-type | 9.75e-05 | 5 | 59 | 2 | IPR002717 | |
| Domain | MYST_HAT | 9.75e-05 | 5 | 59 | 2 | PS51726 | |
| Domain | ZINC_FINGER_C2H2_2 | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 1.42e-04 | 775 | 59 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 1.45e-04 | 777 | 59 | 10 | PS00028 |
| Domain | Znf_C2H2 | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 1.93e-04 | 805 | 59 | 10 | IPR007087 |
| Domain | AP_complex_ssu | 2.04e-04 | 7 | 59 | 2 | IPR016635 | |
| Domain | Carb_sulfotransferase-rel | 2.04e-04 | 7 | 59 | 2 | IPR018011 | |
| Domain | zf-C2H2 | BCL6B ZBTB46 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 3.02e-04 | 693 | 59 | 9 | PF00096 |
| Domain | CLAT_ADAPTOR_S | 3.48e-04 | 9 | 59 | 2 | PS00989 | |
| Domain | Clathrin_sm-chain_CS | 6.34e-04 | 12 | 59 | 2 | IPR000804 | |
| Domain | Sulfotransfer_2 | 6.34e-04 | 12 | 59 | 2 | PF03567 | |
| Domain | Sulfotransferase | 6.34e-04 | 12 | 59 | 2 | IPR005331 | |
| Domain | H15 | 7.48e-04 | 13 | 59 | 2 | SM00526 | |
| Domain | H15 | 7.48e-04 | 13 | 59 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 8.71e-04 | 14 | 59 | 2 | IPR005818 | |
| Domain | Dynein_HC_stalk | 8.71e-04 | 14 | 59 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.71e-04 | 14 | 59 | 2 | IPR013602 | |
| Domain | DHC_N2 | 8.71e-04 | 14 | 59 | 2 | PF08393 | |
| Domain | MT | 8.71e-04 | 14 | 59 | 2 | PF12777 | |
| Domain | DHC_fam | 1.00e-03 | 15 | 59 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.00e-03 | 15 | 59 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.00e-03 | 15 | 59 | 2 | PF03028 | |
| Domain | TSP1 | 1.14e-03 | 65 | 59 | 3 | SM00209 | |
| Domain | TSP1_rpt | 1.14e-03 | 65 | 59 | 3 | IPR000884 | |
| Domain | TSP1 | 1.14e-03 | 65 | 59 | 3 | PS50092 | |
| Domain | Clat_adaptor_s | 1.14e-03 | 16 | 59 | 2 | PF01217 | |
| Domain | AP_mu_sigma_su | 1.14e-03 | 16 | 59 | 2 | IPR022775 | |
| Domain | - | 3.18e-03 | 93 | 59 | 3 | 1.10.533.10 | |
| Domain | Longin-like_dom | 3.52e-03 | 28 | 59 | 2 | IPR011012 | |
| Domain | DEATH-like_dom | 3.79e-03 | 99 | 59 | 3 | IPR011029 | |
| Domain | - | 7.08e-03 | 40 | 59 | 2 | 3.40.630.30 | |
| Domain | BTB | 8.24e-03 | 131 | 59 | 3 | PF00651 | |
| Domain | Acyl_CoA_acyltransferase | 8.90e-03 | 45 | 59 | 2 | IPR016181 | |
| Domain | Znf_FYVE_PHD | 1.13e-02 | 147 | 59 | 3 | IPR011011 | |
| Domain | BTB | 1.41e-02 | 160 | 59 | 3 | PS50097 | |
| Pathway | REACTOME_GLUCURONIDATION | 1.34e-08 | 25 | 45 | 5 | M17787 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 1.34e-08 | 25 | 45 | 5 | M605 | |
| Pathway | WP_GLUCURONIDATION | 1.65e-08 | 26 | 45 | 5 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 2.45e-08 | 28 | 45 | 5 | M19580 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 8.86e-08 | 14 | 45 | 4 | M39328 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.81e-07 | 41 | 45 | 5 | M7399 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 5.55e-07 | 51 | 45 | 5 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.13e-07 | 52 | 45 | 5 | M14171 | |
| Pathway | WP_ESTROGEN_METABOLISM | 6.35e-07 | 22 | 45 | 4 | MM15888 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 8.14e-07 | 55 | 45 | 5 | M14933 | |
| Pathway | REACTOME_GLUCURONIDATION | 9.19e-07 | 24 | 45 | 4 | MM14599 | |
| Pathway | WP_GLUCURONIDATION | 1.09e-06 | 25 | 45 | 4 | MM15820 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.75e-06 | 64 | 45 | 5 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 2.73e-06 | 70 | 45 | 5 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.15e-06 | 72 | 45 | 5 | M9257 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 6.87e-06 | 39 | 45 | 4 | MM15695 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 8.51e-06 | 153 | 45 | 6 | MM15844 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.12e-05 | 44 | 45 | 4 | M45014 | |
| Pathway | REACTOME_ASPIRIN_ADME | 1.23e-05 | 45 | 45 | 4 | MM15694 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.36e-05 | 183 | 45 | 6 | M39588 | |
| Pathway | REACTOME_DRUG_ADME | 2.41e-05 | 109 | 45 | 5 | M45012 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.41e-05 | 109 | 45 | 5 | M18788 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 9.43e-05 | 145 | 45 | 5 | M45512 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.05e-04 | 29 | 45 | 3 | M45015 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 3.68e-04 | 107 | 45 | 4 | MM14595 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 3.93e-04 | 45 | 45 | 3 | M39615 | |
| Pathway | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | 4.41e-04 | 10 | 45 | 2 | M17019 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 5.38e-04 | 11 | 45 | 2 | MM15049 | |
| Pathway | REACTOME_DRUG_ADME | 5.51e-04 | 119 | 45 | 4 | MM15692 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 6.44e-04 | 12 | 45 | 2 | M39611 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 6.44e-04 | 12 | 45 | 2 | M10960 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 6.50e-04 | 220 | 45 | 5 | M10320 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.16e-03 | 16 | 45 | 2 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.16e-03 | 16 | 45 | 2 | MM15050 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 1.48e-03 | 18 | 45 | 2 | M39424 | |
| Pathway | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | 2.01e-03 | 21 | 45 | 2 | M12347 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.01e-03 | 21 | 45 | 2 | M39631 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 2.63e-03 | 24 | 45 | 2 | M46445 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 3.57e-03 | 28 | 45 | 2 | M11362 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 4.37e-03 | 31 | 45 | 2 | M39476 | |
| Pubmed | 7.19e-13 | 8 | 60 | 5 | 17179145 | ||
| Pubmed | 7.19e-13 | 8 | 60 | 5 | 20610558 | ||
| Pubmed | 1.61e-12 | 9 | 60 | 5 | 22511988 | ||
| Pubmed | 3.23e-12 | 10 | 60 | 5 | 23642732 | ||
| Pubmed | 3.23e-12 | 10 | 60 | 5 | 11465080 | ||
| Pubmed | 3.23e-12 | 10 | 60 | 5 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.23e-12 | 10 | 60 | 5 | 22558097 | |
| Pubmed | 1.01e-11 | 12 | 60 | 5 | 19419973 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 1.01e-11 | 12 | 60 | 5 | 20308471 | |
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.01e-11 | 12 | 60 | 5 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.64e-11 | 13 | 60 | 5 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.64e-11 | 13 | 60 | 5 | 25246029 | |
| Pubmed | 2.55e-11 | 14 | 60 | 5 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 2.55e-11 | 14 | 60 | 5 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 2.55e-11 | 14 | 60 | 5 | 14672974 | |
| Pubmed | 2.55e-11 | 14 | 60 | 5 | 9295054 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 5.55e-11 | 16 | 60 | 5 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 7.85e-11 | 17 | 60 | 5 | 20639394 | |
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 20297805 | ||
| Pubmed | 1.20e-10 | 6 | 60 | 4 | 32527940 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 1.47e-10 | 19 | 60 | 5 | 23281178 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 2.79e-10 | 7 | 60 | 4 | 8467709 | |
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 8464825 | ||
| Pubmed | 2.79e-10 | 7 | 60 | 4 | 27514509 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 5.34e-10 | 24 | 60 | 5 | 24625756 | |
| Pubmed | 5.57e-10 | 8 | 60 | 4 | 18052087 | ||
| Pubmed | 2.62e-09 | 11 | 60 | 4 | 18695635 | ||
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 29519853 | ||
| Pubmed | Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. | 4.88e-09 | 3 | 60 | 3 | 20007669 | |
| Pubmed | 4.88e-09 | 3 | 60 | 3 | 12847094 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 17558305 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.95e-08 | 4 | 60 | 3 | 2108603 | |
| Pubmed | 2.40e-08 | 18 | 60 | 4 | 20056724 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 20565459 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 15057901 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 5.04e-08 | 57 | 60 | 5 | 21886157 | |
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 9.73e-08 | 6 | 60 | 3 | 19204906 | |
| Pubmed | 1.06e-07 | 66 | 60 | 5 | 19898482 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 15319294 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 1339448 | ||
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 4.07e-07 | 9 | 60 | 3 | 20732626 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11677206 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22031623 | ||
| Pubmed | Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10. | 2.93e-06 | 2 | 60 | 2 | 10497143 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25899702 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 18568343 | ||
| Pubmed | Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. | 2.93e-06 | 2 | 60 | 2 | 17603215 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15709193 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 12944498 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 25547628 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 22901212 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 39505971 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9647757 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 17529886 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27185879 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20089735 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 11901093 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24150941 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19225446 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15247627 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19712005 | ||
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 8.77e-06 | 3 | 60 | 2 | 36754959 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23789755 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 12623074 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19364970 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17406868 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23063713 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 16636344 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23721685 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19244109 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19996319 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 36571650 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 26247833 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 16397224 | ||
| Pubmed | Linkage disequilibrium of UGT1A1 *6 and UGT1A1 *28 in relation to UGT1A6 and UGT1A7 polymorphisms. | 8.77e-06 | 3 | 60 | 2 | 16969497 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 12732365 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17339869 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 8.77e-06 | 3 | 60 | 2 | 24453052 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 20860988 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 24255116 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 8276413 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 1634050 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 18946804 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 9271343 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20147615 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17965524 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 21880731 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 17980166 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 23700788 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 1898728 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 20628391 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 8280139 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 2040623 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 15855726 | ||
| Pubmed | 1.98e-05 | 190 | 60 | 5 | 24816252 | ||
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | 2.71e-05 | 203 | 60 | 5 | 16916647 | |
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 17182677 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 17479406 | ||
| Pubmed | 2.92e-05 | 5 | 60 | 2 | 17072959 | ||
| Pubmed | MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. | 2.92e-05 | 5 | 60 | 2 | 11965546 | |
| Interaction | UGT1A9 interactions | 7.02e-06 | 13 | 60 | 3 | int:UGT1A9 | |
| Interaction | UGT1A7 interactions | 2.49e-05 | 57 | 60 | 4 | int:UGT1A7 | |
| Interaction | UGT1A8 interactions | 2.61e-05 | 3 | 60 | 2 | int:UGT1A8 | |
| Cytoband | 2q37 | 5.32e-10 | 31 | 60 | 5 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 1.21e-05 | 226 | 60 | 5 | chr2q37 | |
| Cytoband | 18q11.2 | 1.75e-03 | 47 | 60 | 2 | 18q11.2 | |
| GeneFamily | UDP glucuronosyltransferases | 1.15e-08 | 32 | 43 | 5 | 363 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BCL6B ZBTB46 ZNF800 ZNF37A ZFP30 ZNF335 ZNF780B ZBTB4 ZNF749 ZNF625 | 5.35e-06 | 718 | 43 | 10 | 28 |
| GeneFamily | Purinergic receptors P2Y | 2.46e-04 | 10 | 43 | 2 | 213 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 6.49e-04 | 16 | 43 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 7.35e-04 | 17 | 43 | 2 | 486 | |
| GeneFamily | CD molecules|Complement system|LY6/PLAUR domain containing | 2.95e-03 | 34 | 43 | 2 | 1226 | |
| GeneFamily | Sulfotransferases, membrane bound | 3.49e-03 | 37 | 43 | 2 | 763 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.96e-03 | 134 | 43 | 3 | 861 | |
| GeneFamily | PHD finger proteins | 1.94e-02 | 90 | 43 | 2 | 88 | |
| Drug | AC1MRQNQ | 1.23e-11 | 9 | 59 | 5 | CID003522271 | |
| Drug | DHPASiU | 1.23e-11 | 9 | 59 | 5 | CID000197602 | |
| Drug | Chebi:32663 | 1.23e-11 | 9 | 59 | 5 | CID005460873 | |
| Drug | 3-iodophenol | 1.23e-11 | 9 | 59 | 5 | CID000012272 | |
| Drug | AC1L4J7U | 1.23e-11 | 9 | 59 | 5 | CID000186631 | |
| Drug | 4-nitrophenyl)imidazole | 4.48e-11 | 11 | 59 | 5 | CID000123155 | |
| Drug | AC1O5XMV | 4.48e-11 | 11 | 59 | 5 | CID006442661 | |
| Drug | N-OH-DABZ | 7.67e-11 | 12 | 59 | 5 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 7.67e-11 | 12 | 59 | 5 | CID000088735 | |
| Drug | 2,4,6-TCB | 7.67e-11 | 12 | 59 | 5 | CID000037247 | |
| Drug | 7,7,7-triphenylheptanoic acid | 7.67e-11 | 12 | 59 | 5 | CID000276709 | |
| Drug | nonanoyl-N-methylglucamide | 7.67e-11 | 12 | 59 | 5 | CID000160090 | |
| Drug | CARMINE | 8.40e-11 | 28 | 59 | 6 | CID000014749 | |
| Drug | tritanol | 1.24e-10 | 13 | 59 | 5 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.24e-10 | 13 | 59 | 5 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.24e-10 | 13 | 59 | 5 | CID000000411 | |
| Drug | propranolol glucuronide | 1.93e-10 | 14 | 59 | 5 | CID000119515 | |
| Drug | PCB-61 | 1.93e-10 | 14 | 59 | 5 | CID000036401 | |
| Drug | naringenin chalcone | 2.03e-10 | 5 | 59 | 4 | ctd:C027329 | |
| Drug | anthrarobin | 2.03e-10 | 5 | 59 | 4 | ctd:C032186 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 2.89e-10 | 15 | 59 | 5 | CID000040469 | |
| Drug | coumarin-3-carboxylic acid | 2.89e-10 | 15 | 59 | 5 | CID000010752 | |
| Drug | sulforaphane nitrile | 2.89e-10 | 15 | 59 | 5 | CID000543743 | |
| Drug | afloqualone | 2.89e-10 | 15 | 59 | 5 | CID000002040 | |
| Drug | naphthyl sulphate | 2.89e-10 | 15 | 59 | 5 | CID000114775 | |
| Drug | quercetin-3,4'-diglucoside | 4.20e-10 | 16 | 59 | 5 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 4.20e-10 | 16 | 59 | 5 | CID000040003 | |
| Drug | bilirubin-phosphate | 4.20e-10 | 16 | 59 | 5 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 5.94e-10 | 17 | 59 | 5 | CID000003573 | |
| Drug | 6-hydroxychrysene | 5.94e-10 | 17 | 59 | 5 | CID000037766 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 6.08e-10 | 6 | 59 | 4 | ctd:C543211 | |
| Drug | alloin | 6.08e-10 | 6 | 59 | 4 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 6.08e-10 | 6 | 59 | 4 | ctd:C107497 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 8.20e-10 | 18 | 59 | 5 | CID000152226 | |
| Drug | Br 2 | 8.20e-10 | 18 | 59 | 5 | CID003060900 | |
| Drug | SureCN12722713 | 8.20e-10 | 18 | 59 | 5 | CID005488034 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 8.20e-10 | 18 | 59 | 5 | CID000036614 | |
| Drug | ApApG | 8.20e-10 | 18 | 59 | 5 | CID003081975 | |
| Drug | C1 11-32 | 8.20e-10 | 18 | 59 | 5 | CID000443077 | |
| Drug | C11131 | 8.20e-10 | 18 | 59 | 5 | CID000443076 | |
| Drug | almokalant | 1.11e-09 | 19 | 59 | 5 | CID003033962 | |
| Drug | 9-OH-risperidone | 1.11e-09 | 19 | 59 | 5 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 1.11e-09 | 19 | 59 | 5 | CID000091433 | |
| Drug | 5-hydroxytryptophol | 1.14e-09 | 42 | 59 | 6 | CID000009061 | |
| Drug | 2',4'-dihydroxychalcone | 1.41e-09 | 7 | 59 | 4 | ctd:C059354 | |
| Drug | tectochrysin | 1.48e-09 | 20 | 59 | 5 | CID005281954 | |
| Drug | AC1L1OBF | 1.48e-09 | 20 | 59 | 5 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.48e-09 | 20 | 59 | 5 | CID000116545 | |
| Drug | estriol-16-glucuronide | 1.94e-09 | 21 | 59 | 5 | CID000122281 | |
| Drug | dulcin | 1.94e-09 | 21 | 59 | 5 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.94e-09 | 21 | 59 | 5 | CID000069186 | |
| Drug | amonafide | 2.50e-09 | 22 | 59 | 5 | CID000050515 | |
| Drug | N-methylpiperazine | 2.50e-09 | 22 | 59 | 5 | CID000053167 | |
| Drug | 1,4-dihydroxyanthraquinone | 2.82e-09 | 8 | 59 | 4 | ctd:C034890 | |
| Drug | amidoxime | 3.19e-09 | 23 | 59 | 5 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 3.19e-09 | 23 | 59 | 5 | CID000066651 | |
| Drug | phenanthridine | 3.19e-09 | 23 | 59 | 5 | CID000009189 | |
| Drug | 1-hydroxypyrene | 3.84e-09 | 51 | 59 | 6 | ctd:C033146 | |
| Drug | C2-MPAcid | 3.84e-09 | 51 | 59 | 6 | CID000508230 | |
| Drug | AS-3201 | 4.02e-09 | 24 | 59 | 5 | CID000153948 | |
| Drug | 5-MOP | 5.02e-09 | 25 | 59 | 5 | CID000002355 | |
| Drug | Hymecromone | 5.02e-09 | 25 | 59 | 5 | ctd:D006923 | |
| Drug | AzMC | 5.02e-09 | 25 | 59 | 5 | CID000064986 | |
| Drug | N-acetylbenzidine | 5.02e-09 | 25 | 59 | 5 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 5.02e-09 | 25 | 59 | 5 | CID000006796 | |
| Drug | N-phenylmaleimide | 5.02e-09 | 25 | 59 | 5 | CID000013662 | |
| Drug | Scopoletin | 7.59e-09 | 27 | 59 | 5 | ctd:D012603 | |
| Drug | DiMeIQx | 7.59e-09 | 27 | 59 | 5 | CID000104739 | |
| Drug | licochalcone A | 7.59e-09 | 27 | 59 | 5 | ctd:C070840 | |
| Drug | diflunisal | 7.59e-09 | 27 | 59 | 5 | CID000003059 | |
| Drug | 2,6-dihydroxyanthraquinone | 8.44e-09 | 10 | 59 | 4 | ctd:C034889 | |
| Drug | Glucuronides | 8.44e-09 | 10 | 59 | 4 | ctd:D020719 | |
| Drug | N-hydroxy-4-aminobiphenyl | 9.23e-09 | 28 | 59 | 5 | CID000081261 | |
| Drug | erucin | 9.23e-09 | 28 | 59 | 5 | CID000078160 | |
| Drug | H-Ni | 9.23e-09 | 28 | 59 | 5 | CID000445665 | |
| Drug | AC1L1JAL | 1.11e-08 | 29 | 59 | 5 | CID000004954 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 1.11e-08 | 29 | 59 | 5 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 1.11e-08 | 29 | 59 | 5 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 1.11e-08 | 29 | 59 | 5 | CID000125641 | |
| Drug | iberin | 1.11e-08 | 29 | 59 | 5 | CID000010455 | |
| Drug | tolcapone | 1.33e-08 | 30 | 59 | 5 | CID004659569 | |
| Drug | paricalcitol | 1.33e-08 | 30 | 59 | 5 | CID005281104 | |
| Drug | AC1L9E0Q | 1.33e-08 | 30 | 59 | 5 | CID000443095 | |
| Drug | dihydroartemisinin | 1.33e-08 | 30 | 59 | 5 | CID000107770 | |
| Drug | 4-ethylphenol | 1.59e-08 | 31 | 59 | 5 | CID000031242 | |
| Drug | PCB 156 | 1.59e-08 | 31 | 59 | 5 | CID000038019 | |
| Drug | 4'-HPPH | 1.59e-08 | 31 | 59 | 5 | CID000017732 | |
| Drug | indole-2-carboxylic acid | 1.88e-08 | 32 | 59 | 5 | CID000072899 | |
| Drug | NNAL | 1.88e-08 | 32 | 59 | 5 | CID000104856 | |
| Drug | Muracein C | 1.88e-08 | 32 | 59 | 5 | CID003086323 | |
| Drug | 4-hydroxyestrone | 1.98e-08 | 12 | 59 | 4 | ctd:C026418 | |
| Drug | AC1Q6OQG | 2.21e-08 | 33 | 59 | 5 | CID000009686 | |
| Drug | R(-)-Denopamine | 2.21e-08 | 33 | 59 | 5 | CID000003818 | |
| Drug | 6-methylsalicylic acid | 2.21e-08 | 33 | 59 | 5 | CID000011279 | |
| Drug | BP-3,6-quinol | 2.21e-08 | 33 | 59 | 5 | CID000119292 | |
| Drug | norbuprenorphine | 2.21e-08 | 33 | 59 | 5 | CID000114976 | |
| Drug | geniposide | 2.21e-08 | 33 | 59 | 5 | CID000107848 | |
| Drug | estragole | 2.58e-08 | 34 | 59 | 5 | CID000008815 | |
| Drug | 2-hydroxyestrone | 2.86e-08 | 13 | 59 | 4 | ctd:C024980 | |
| Drug | alizarin | 2.86e-08 | 13 | 59 | 4 | ctd:C010078 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 2.05e-14 | 5 | 56 | 5 | EFO_0801060 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 2.05e-14 | 5 | 56 | 5 | EFO_0801853 | |
| Disease | X-21339 measurement | 4.29e-13 | 7 | 56 | 5 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0022118 | |
| Disease | X-24849 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0800909 | |
| Disease | X-11530 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0800696 | |
| Disease | serum N-desmethylclozapine measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0600043 | |
| Disease | X-10458 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0800692 | |
| Disease | plasma clozapine measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.14e-12 | 8 | 56 | 5 | EFO_0800766 | |
| Disease | X-11442 measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0801037 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0802127 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0801036 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.57e-12 | 9 | 56 | 5 | EFO_0004570, GO_0009410 | |
| Disease | X-11880 measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.57e-12 | 9 | 56 | 5 | EFO_0020691 | |
| Disease | X-21448 measurement | 5.13e-12 | 10 | 56 | 5 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 5.13e-12 | 10 | 56 | 5 | EFO_0802185 | |
| Disease | bilirubin measurement, response to tenofovir | 5.13e-12 | 10 | 56 | 5 | EFO_0004570, EFO_0009279 | |
| Disease | X-23974 measurement | 5.13e-12 | 10 | 56 | 5 | EFO_0800867 | |
| Disease | pregnenetriol sulfate measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0600039 | |
| Disease | insomnia, bilirubin measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0004570, EFO_0004698 | |
| Disease | histidine betaine (hercynine) measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0800972 | |
| Disease | aldosterone measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0010219 | |
| Disease | X-21796 measurement | 9.39e-12 | 11 | 56 | 5 | EFO_0800825 | |
| Disease | biliverdin measurement | 1.61e-11 | 12 | 56 | 5 | EFO_0021033 | |
| Disease | p-cresol glucuronide measurement | 1.61e-11 | 12 | 56 | 5 | EFO_0800079 | |
| Disease | retinol dehydrogenase 16 measurement | 2.61e-11 | 13 | 56 | 5 | EFO_0802007 | |
| Disease | pregnenetriol disulfate measurement | 2.61e-11 | 13 | 56 | 5 | EFO_0800587 | |
| Disease | 5-hydroxyindole sulfate measurement | 5.81e-11 | 5 | 56 | 4 | EFO_0800085 | |
| Disease | X-21441 measurement | 1.25e-10 | 17 | 56 | 5 | EFO_0800814 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.25e-10 | 17 | 56 | 5 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 1.72e-10 | 18 | 56 | 5 | EFO_0801382 | |
| Disease | tissue factor measurement | 4.08e-10 | 21 | 56 | 5 | EFO_0010623 | |
| Disease | neuroblastoma, cutaneous melanoma | 1.95e-09 | 28 | 56 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 2.35e-09 | 29 | 56 | 5 | EFO_0010551 | |
| Disease | response to dolutegravir | 2.82e-09 | 30 | 56 | 5 | EFO_0600017 | |
| Disease | blood 4-oxo-retinoic acid measurement | 6.47e-09 | 3 | 56 | 3 | EFO_0022216 | |
| Disease | indole-3-carboxylate measurement | 6.47e-09 | 3 | 56 | 3 | EFO_0800043 | |
| Disease | vitamin D deficiency | 8.53e-09 | 37 | 56 | 5 | EFO_0003762 | |
| Disease | thyroxine measurement | 1.20e-08 | 83 | 56 | 6 | EFO_0005130 | |
| Disease | urate measurement, bone density | UGT1A10 UGT1A8 UGT1A7 UGT1A6 NXPH1 TPH2 UGT1A9 QRICH1 KAT6B CABIN1 DNAH8 | 2.01e-08 | 619 | 56 | 11 | EFO_0003923, EFO_0004531 |
| Disease | vitamin D measurement, COVID-19 | 3.67e-08 | 49 | 56 | 5 | EFO_0004631, MONDO_0100096 | |
| Disease | gallstones | 5.85e-08 | 108 | 56 | 6 | EFO_0004210 | |
| Disease | urate measurement, spine bone mineral density | 8.70e-08 | 58 | 56 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 1.29e-07 | 6 | 56 | 3 | EFO_0800566 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.65e-07 | 147 | 56 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | hormone measurement | 5.65e-07 | 84 | 56 | 5 | EFO_0004730 | |
| Disease | cholelithiasis | 7.13e-07 | 88 | 56 | 5 | EFO_0004799 | |
| Disease | indoleacetate measurement | 7.70e-07 | 10 | 56 | 3 | EFO_0021015 | |
| Disease | X-24588 measurement | 1.83e-06 | 13 | 56 | 3 | EFO_0800898 | |
| Disease | vitamin D measurement | 4.19e-05 | 336 | 56 | 6 | EFO_0004631 | |
| Disease | dodecanedioate measurement | 2.31e-04 | 12 | 56 | 2 | EFO_0021054 | |
| Disease | posterior cingulate cortex volume measurement | 4.72e-04 | 17 | 56 | 2 | EFO_0010324 | |
| Disease | metabolite measurement | 6.61e-04 | 560 | 56 | 6 | EFO_0004725 | |
| Disease | free androgen index | 7.16e-04 | 374 | 56 | 5 | EFO_0007005 | |
| Disease | gastric ulcer | 7.26e-04 | 21 | 56 | 2 | EFO_0009454 | |
| Disease | bilirubin measurement | 1.50e-03 | 442 | 56 | 5 | EFO_0004570 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.65e-03 | 914 | 56 | 7 | EFO_0004532 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCLYFYCKFLWRCLK | 11 | Q8N336 | |
| CICELYFYKAVCKKF | 151 | Q9H6U8 | |
| KVVYKRYASLYFCCA | 56 | P61966 | |
| IPFFKYCLLRKSFTC | 361 | Q96M86 | |
| SKCILYCFYKNIVLY | 856 | Q9Y2Q0 | |
| YCPLVLKFKFCSRAY | 1091 | Q9UKP5 | |
| CPIKLYDFYLFKCPQ | 701 | Q2TAL8 | |
| EYARLPKLYLCEFCL | 741 | Q8WYB5 | |
| KLVYKRYASLYFCCA | 56 | Q96PC3 | |
| FPKYLRCYRCLLETK | 56 | Q5SRR4 | |
| LLGIYPKDYKSCCYK | 1176 | O00370 | |
| IPKTGFYCKLCSLFY | 796 | P43243 | |
| KCAIGYYNFPFCLRI | 456 | Q16787 | |
| EPMPFFYLKCCKIRY | 106 | Q17RY6 | |
| SPDYYLRLCLKRFTC | 136 | Q6ZVW7 | |
| LYFLCISCKKAAFPY | 71 | Q8TBE3 | |
| ISCKKAAFPYRHYCT | 76 | Q8TBE3 | |
| KPCGKCYFYLLISKT | 211 | Q9P287 | |
| FCFYTGYKIPLCKTL | 4146 | Q96JB1 | |
| CGLAFLSYKYCKRSK | 1896 | P09848 | |
| DRLVYFCCFFKDPKR | 306 | Q96MN2 | |
| KLAFCYISFVCIYGL | 311 | Q6NSJ5 | |
| ACLDPFIYFFLCKSF | 291 | Q9H244 | |
| PIMCAYKLCKVEFRY | 186 | Q9BZ72 | |
| YSRLPKLYLCEFCLK | 531 | Q92794 | |
| ALPAFKYYVTCACLI | 596 | Q08462 | |
| KPYKCQLCRSSFRYK | 326 | Q8N143 | |
| CFYCLYSFPSKKSKA | 946 | Q9Y6J0 | |
| PLKFYKKIYFCHSCQ | 591 | Q8NA54 | |
| NLLKTKLCPYFYVCT | 271 | Q9NYP3 | |
| QLKKKCFTLLCYYDP | 171 | Q9H6D7 | |
| FFYLKRSSKLPRACY | 166 | Q96HA4 | |
| FQRALCLLCFYLKYL | 101 | O00398 | |
| FSKSACIYNPIIYCF | 291 | P03999 | |
| IYKFSKCCFSQPVYP | 456 | Q9BYJ4 | |
| RCKRQFYLYKGKCLP | 106 | Q2I0M5 | |
| CSKPFKVICIYISFY | 231 | P58417 | |
| VLPLLCKDYCKEFFY | 136 | Q96QV1 | |
| LCYPCLINYDFVGKF | 356 | Q7L1S5 | |
| RYRFLYCYVPKVACS | 146 | Q8NCH0 | |
| KPYECYACGKAFLRK | 381 | P17032 | |
| PYECKECQKFFRRYS | 381 | Q9Y2G7 | |
| KPYECSNCGKFLRYR | 666 | O43361 | |
| FITFKCCAYGYRKCL | 501 | Q9HAW8 | |
| KYPCRYCEKVFALAE | 336 | Q9P1Z0 | |
| ICSIFRKYPKYNLCA | 301 | Q70EL3 | |
| FITFKCCAYGYRKCL | 501 | O60656 | |
| YFLVCIAKEYLLFCP | 456 | Q8NDW8 | |
| PFVCKECRKTFRYHY | 696 | Q9Y6R6 | |
| CREYLKNFPLLTKYC | 236 | Q8IWU9 | |
| VTLCFFCLLYGKYVS | 166 | Q9H0R3 | |
| VKFYKCPLCTYETRR | 516 | Q2TB10 | |
| CTYCKKAFSDLPYFR | 71 | Q96I27 | |
| VAFITFKCCAYGYRK | 501 | P19224 | |
| CKYARFDFMLYAKPC | 3706 | Q5T4S7 | |
| DKPFKCSFCPYRTFR | 646 | Q9H4Z2 | |
| LYCKASPATQIYFKC | 81 | O95185 | |
| EKCYLCKSLVPFREY | 561 | Q96RL1 | |
| FITFKCCAYGYRKCL | 501 | Q9HAW7 | |
| FTVIRKKFKCPYCSF | 411 | Q86UZ6 | |
| KIKSCYYLPCFVTSK | 146 | P35625 | |
| FITFKCCAYGYRKCL | 501 | Q9HAW9 |